MedPath

Analysis of clinical features and prognosis of anti-neutrophil cytoplasmic antibody-associated vasculitis

Not Applicable
Conditions
anti-neutrophil cytoplasmic antibody associated vasculitis
Registration Number
JPRN-UMIN000036873
Lead Sponsor
Jichimedical University
Brief Summary

The multivariable Cox proportional hazards regression analysis showed that age over than 65: HR 1.69, 95 percent CI 1.07 to 2.81, p equal 0.025, performance status of 3 to 4: HR 1.98, 95 percent CI 1.21 to 3.23, p equal 0.008, cumulative dose of prednisolone over than 1,500mg : HR 2.21, 95 percent CI 1.37 to 3.81, p lower than 0.001, and oral cyclophosphamide: HR 1.84, 95 percent CI 1.13 to 3.00, p equal 0.016 were independent risk factors for immunosuppressant discontinuation.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
162
Inclusion Criteria

Not provided

Exclusion Criteria

none

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To study outcomes of relapses, occurrences of adverse events, discontinuing of immunosuppressants, and survival rate, for five years.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath